Synovus Financial’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-17,713
| Closed | -$1.75M | – | 1630 |
|
|
2019
Q3 | $1.75M | Sell |
17,713
-847
| -5% | -$80.5K | 0.03% | 246 |
|
|
2019
Q2 | $1.71M | Sell |
18,560
-12,717
| -41% | -$1.21M | 0.03% | 246 |
|
|
2019
Q1 | $2.95M | Sell |
31,277
-23,496
| -43% | -$2.05M | 0.05% | 177 |
|
|
2018
Q4 | $3.5M | Sell |
54,773
-2,121
| -4% | -$157K | 0.06% | 155 |
|
|
2018
Q3 | $5.08M | Buy |
56,894
+6,969
| +14% | +$616K | 0.08% | 139 |
|
|
2018
Q2 | $3.97M | Buy |
49,925
+8,585
| +21% | +$713K | 0.07% | 152 |
|
|
2018
Q1 | $3.68M | Sell |
41,340
-2,432
| -6% | -$233K | 0.06% | 155 |
|
|
2017
Q4 | $4.55M | Sell |
43,772
-9,088
| -17% | -$1.03M | 0.08% | 128 |
|
|
2017
Q3 | $7.72M | Sell |
52,860
-2,411
| -4% | -$328K | 0.15% | 98 |
|
|
2017
Q2 | $7.16M | Buy |
55,271
+466
| +0.9% | +$57.1K | 0.14% | 98 |
|
|
2017
Q1 | $6.8M | Buy |
54,805
+1,670
| +3% | +$200K | 0.14% | 100 |
|
|
2016
Q4 | $6.17M | Buy |
53,135
+5,948
| +13% | +$662K | 0.14% | 101 |
|
|
2016
Q3 | $4.93M | Buy |
47,187
+22,580
| +92% | +$2.44M | 0.12% | 108 |
|
|
2016
Q2 | $2.43M | Sell |
24,607
-12
| -0% | -$1.24K | 0.06% | 149 |
|
|
2016
Q1 | $2.46M | Buy |
24,619
+16,048
| +187% | +$1.65M | 0.06% | 150 |
|
|
2015
Q4 | $1.03M | Buy |
8,571
+1,222
| +17% | +$141K | 0.03% | 255 |
|
|
2015
Q3 | $795K | Buy |
7,349
+769
| +12% | +$95.4K | 0.02% | 298 |
|
|
2015
Q2 | $763K | Sell |
6,580
-2,960
| -31% | -$338K | 0.02% | 305 |
|
|
2015
Q1 | $1.1M | Sell |
9,540
-54
| -0.6% | -$6.45K | 0.03% | 266 |
|
|
2014
Q4 | $1.07M | Sell |
9,594
-274
| -3% | -$28.9K | 0.03% | 268 |
|
|
2014
Q3 | $937K | Buy |
9,868
+3,186
| +48% | +$288K | 0.03% | 275 |
|
|
2014
Q2 | $574K | Hold |
6,682
| – | – | 0.02% | 307 |
|
|
2014
Q1 | $466K | Sell |
6,682
-17,434
| -72% | -$1.38M | 0.01% | 329 |
|
|
2013
Q4 | $2.04M | Buy |
24,116
+300
| +1% | +$23.7K | 0.06% | 156 |
|
|
2013
Q3 | $1.83M | Buy |
23,816
+17,440
| +274% | +$1.22M | 0.06% | 152 |
|
|
2013
Q2 | $373K | Buy |
+6,376
| New | +$384K | 0.01% | 323 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Synovus Financial's CELG Position: Q4 2019 in Review
Synovus Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 17,713 shares — an estimated $1.75M sold.
Synovus Financial first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $7.72M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Synovus Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Synovus Financial sold 17,713 Celgene Corp shares in Q4 2019, an estimated $1.75M.
- Synovus Financial first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Synovus Financial's Celgene Corp position peaked at $7.72M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Synovus Financial's 13F filing for Q4 2019, filed 6 Feb 2020.